Clinical trial · Interventional
Use of Compressed Sensing in Breast MRI
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Breast MRI is increasingly important in breast screening imaging. It is currently based on dynamic sequences after contrast injection whose temporal resolution must be less than 90 seconds with dynamic acquisitions at different times. These curves profiles are designed to differentiate benign from malignant lesions. Recently, Mann et al, (2014) showed that increasing the temporal resolution of dynamic acquisitions; lesion enhancement curves over time were more accurate than the curves usually performed. It seems necessary to work on sequences having better temporal resolution without compromising however spatial resolution.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 3.0 Tesla in Magnetic Resonance Imaging | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 3.0 Tesla in Magnetic Resonance Imaging
- interventionNames
- Other: 3.0 Tesla in Magnetic Resonance Imaging
Primary outcomes (1)
- measure
- Agreement between compressed sensing and standard image acquisition
- timeFrame
- 1 day
- description
- Agreement between compressed sensing and standard image acquisition is defined by percentage of lesions detected by both modes of acquisitions
Secondary outcomes (2)
- measure
- Analysis of dammage contours
- timeFrame
- 1 day
- description
- Analysis of lesions contours will be performed according to Bi-RADS classification
Eligibility
Eligibility (as posted)
- Sex
- Female
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient to benefit a MRI in the assessment for a breast carcinoma * Age \>18 years old * Assessment on 3.0 Tesla in Magnetic Resonance Imaging * ECOG performance status ≤ 3 * Ability to provide an informed written consent form Exclusion Criteria: * Age \< 18 years old * Claustrophobia * Contraindication to the injection of gadolinium contrast medium * Contraindication to MRI * Persons deprived of liberty or under supervision
References
Publications (0)
Data not yet available